COVID-19 in pediatric patients: A case series by Eghbali, Ahmad et al.
  Journal of Cellular & Molecular Anesthesia (JCMA)  
Vol 5, No 1, Winter 2020 
3 
Case report  
 
 
COVID-19 in pediatric patients: A case series 
 
 
Ahmad Eghbali1, Sedighe Shokrollahi1, Nastaran Sadat Mahdavi1, Seyed Alireza Mahdavi1* , Ali Dabbagh2  
 
Abstract 
The COVID-19 pandemic outbreak has affected the global health system with 
an urgent need for more sophisticated studies. One of the prominent aspects of 
COVID-19 is the feature of the disease in pediatric population. In a 
retrospective study, four boys COVID-19 patients confirmed with RT-PCR 
nasotracheal sampling and typical clinical features were assessed. Our patients 
were in a referral children's hospital with different clinical outcomes. Half of 
our patients did not have any underlying disease and were discharged after 
recovery from the disease. Two others had different courses. One with aplastic 
anemia, which died, and the other one with cyanotic congenital heart disease 
receiving treatment. These patients were aged 8-13 years old. COVID-19 
affects pediatric population while the outcome might be better if there is no 
underlying condition. However, any major systemic disease should raise 
caution. 
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Introduction 
Since December 2019, an outbreak of 
coronavirus disease 2019 (COVID-19) has spread 
globally. The current epidemiological and clinical 
features of pediatric patients with COVID-19 is less 
clear yet (1, 2). The milder pattern of disease in 
pediatric patients could be an extraordinary solution to 
the pathogenesis and treatment of the disease (3). We 
retrospectively retrieved data for pediatric patients 
(aged 0–16 years) with confirmed COVID-19 from 
medical records in Mofid Children's Hospital, Shahid 
Beheshti University of Medical Sciences, Tehran, Iran. 
We recorded patients' epidemiological and clinical 
features. 
The study proposal was assessed and approved 
by Research Ethics Committee, Shahid Beheshti 




We present four pediatric cases of coronavirus 
disease 2019 (COVID-19) admitted to Mofid 
Children's Hospital in Tehran (capital city of Iran). All 
patients were male. The youngest was 8 years old and 
the oldest one was 13. All children had at least one 
family member infected with COVID-19. Two patients 
had leukopenia and lymphopenia. The virus that cause 
COVID-19 is SARS-CoV-2. The virus RNA detected 
by RT-PCR test in all four patients. Elevated C-
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reactive protein (CRP) and erythrocyte sedimentation 
rate were detected in all patients. Supportive care, 
antiviral and antibiotic therapy were administered for 
all the patients. Two of four patients were discharged 
within six days after admission with stable general and 
medical conditions. One patient died and another one 
is still hospitalized at the time of submitting this 
manuscript. 
Patient number 1: this patient was an 11 years 
old boy with underlying aplastic anemia. Clinical signs 
and symptoms included fever, cough, tachypnea, 
retraction, crackle and hemoptysis. Imaging studies 
showed white lung in chest X ray (CXR) associated 
with typical CT scan findings. The main laboratory 
data were as follows: white blood cells (WBC) count: 
1100/µL (lymphocytes: 11.5%); hemoglobin 
concentration: 50 mg/L and platelet count: 10000 
cells/mL. However, during the course of the disease, 
the patient progressed towards respiratory distress, 
therefore was intubated and received mechanical 
ventilation. The process went towards full respiratory 
failure and the patient died 8 hours after admission. 
Patient number 2: this was an 8 years old boy 
without any detected underlying disease. His clinical 
signs and symptoms included fever and nonproductive 
cough. CXR and chest CT scanning demonstrated sub-
pleural ground glass opacities. The main laboratory 
data included WBC count 7400/µL (lymphocytes: 
30%); Hemoglobin concentration: 114 mg/L and 
platelet count: 130000 cells/mL. Hydroxychloroquine 
and Oseltamivir was started orally. The patient did not 
experience severe respiratory distress mandating 
mechanical ventilation and was discharged in six days 
with good general condition. 
Patient number 3: this was a 12 years old boy 
without any detected underlying disease. His clinical 
signs and symptoms also included fever and 
nonproductive cough. Again, this patient demonstrated 
sub-pleural ground glass opacities in CXR and chest 
CT scanning. The main laboratory data included WBC 
count 8900/µL (lymphocytes: 41%); Hemoglobin 
concentration: 136 mg/L and platelet count: 215000 
cells/mL. Oral Hydroxychloroquine and Oseltamivir 
was administered. This patient was also discharged in 
7 days with stable clinical conditions. 
Patient number 4: this was a 13 years old boy 
with underlying congenital cyanotic heart disease 
(single ventricle, cyanosis and pulmonary 
hypertension). The clinical signs and symptoms in 
admission included fever, nonproductive cough, and 
tachypnea, fine widespread inspiratory crackles, 
intercostal and subcostal retraction. In CXR and CT 
scanning, sub-pleural ground glass opacities were 
found. The main laboratory data included WBC count 
4600/µL (lymphocytes: 16%);; Hemoglobin 
concentration: 117 mg/L and platelet count 135000 
cells/mL. Treatment included oral 
Hydroxychloroquine, azithromycin, naproxen and 
supplemental oxygen; added with digoxin and 
furosemide for treatment of underlying cardiac disease. 
The patient is still hospitalized and receives care. 
Discussion 
Our experience with these patients showed that 
COVID-19 could affect children; and the outcome 
seems to be highly affected by any underlying systemic 
disease. In an approach similar to adult patients, 
pediatric patients need supportive care with especial 
focus on the respiratory maneuvers (4, 5). Again, 
similar to adult population, imaging studies and RT-
PCR test from nasotracheal samples remains the most 
important confirming tests for any clinical suspicious 
patient (4, 6). Since our center is a referral one and also, 
our experience was on 4 patients, we could not have 
any judgement about the case fatality rate or mortality 
rate in pediatric population (5, 7). In addition, all of our 
patients were boy, which could be meaningful 
regarding male propensity of the disease (3, 8).  
Conclusion 
The current study demonstrates that pediatric 
population should not be considered only as just a 
transmission route. Frank clinical disease with 
considerable morbidity and mortality might occur in 
this age range, while the response to the question that 
why pediatric patients are not affected as much 
severely as adults might be one of the most important 
solutions to the treatment of the disease. 
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